Purchase Order 75N93024P00428
Award Date
3/14/24
Potential Completion Date
3/13/25
Potential Value
$48K
Federal Agency
National Institute of Allergy and Infectious Diseases
Awardee
Illumina, Inc.
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $36,117 firm fixed price purchase order to Illumina, Inc. to provide a NEXTSEQ 1000 SILVER SUPPORT PLAN. The place of performance is Potomac, Maryland and the period of performance is from December 1, 2023 through November 30, 2024. This support plan is likely associated with the NIH's ongoing genomic sequencing and bioinformatics research efforts to...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm-fixed-price purchase order to Illumina, Inc. for a NEXTSEQ 2000 SILVER SUPPORT PLAN. The potential value of the contract is $48,209.00, with a completion date of April 2, 2025. This contract is not set aside and is for the provision of sequencing and array-based solutions to support genomic analysis and life science research. Illumina, a for-profit...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $21,171 firm fixed price purchase order to Illumina, Inc. for the annual renewal of the NextSeq bronze support plan. As a manufacturer and provider of sequencing and array-based solutions, Illumina will deliver maintenance services for the NextSeq sequencing system located in Rockville, Maryland under this contract. No set-aside provision was utilized for this...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases (HHS-NIH-NIAID) awarded a $48,209 firm fixed price purchase order to Illumina, Inc. to provide two Nextseq 2000 Silver Support Plans. The solicitation sought comparable services to support NIAID's genomic research efforts, including full parts, labor, and travel coverage; reagent replacement for hardware failures; remote and on-site technical support; software and...
This is a firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Illumina, Inc. for a NextSeq 2000 Silver Support Plan and Preventive Maintenance with a total ceiling value of $23,717.81. The award does not utilize any set-aside designations. Illumina is a manufacturer and provider of sequencing and array-based solutions for genetic and genomic analysis, and has received prior prime federal contract and sub-grant awards...
This is a $48,209 firm fixed price purchase order awarded by the National Institute on Deafness and Other Communication Disorders (NIDCD), a civilian agency within the National Institutes of Health (NIH), to Illumina, Inc. The contract provides a NEXT SEQ 2000 SILVER SUPPORT PLAN with a completion date of September 12, 2025. Illumina, a for-profit manufacturer of genomic sequencing and analysis equipment and reagents, has previously received other prime federal contracts and subcontracts from...
This is a firm fixed price purchase order awarded by the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Illumina, Inc. for a service agreement renewal and co-term for a NextSeq 2000 Silver Support Plan. The potential value of the award is $29,158.67, and the period of performance runs through July 4, 2024. Illumina is a for-profit manufacturer that has previously provided a range of sequencing systems, reagents, and support services to federal...
This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Illumina, Inc. for a NextSeq 2000 Silver Support Plan. The contract has a ceiling value of $32,657.70 and a period of performance through July 4, 2025. Illumina is a manufacturer of sequencing and genomic analysis instruments and has been awarded other federal prime contracts and subcontracts to provide sequencing systems, reagents, and services to support...
This is a firm fixed-price purchase order valued at $30,221.00 awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Illumina, Inc. The contract is for the annual renewal of the NexSeq Silver Support Plan, which provides maintenance and technical support services for Illumina's DNA sequencing instruments. Illumina is a leading manufacturer of genetic analysis equipment and has been awarded numerous prior federal...
This firm fixed price purchase order contract, valued at $48,209.00, was awarded by the National Institute of Child Health and Human Development (NICHD) at the National Institutes of Health (NIH) to Illumina, Inc. for a one-year Silver Support Plan covering a NextSeq 2000 Sequence Detection System. The contract will run from September 3, 2024 to September 2, 2025. The support plan includes full coverage for repair parts, labor, travel, reagent replacement, annual preventive maintenance, and...